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Summary 
The lkaros gene is essential for lymphoid lineage spec- 
ification. As previously reported, mice homozygous 
for a mutation in the lkaros DNA-binding domain fail to 
generate mature lymphocytes as well as their earliest 
described progenitors. In addition, our studies with 
mice heterozygous for this mutation establish the 
lkaros gene as an essential regulator of T cell prolifera- 
tion. Thymocytes display augmented TCR-mediated 
proliferative responses, and peripheral T cells are au- 
toproliferative. A general lymphoproliferation pre- 
cedes the T cell leukemia and lymphoma that rapidly 
develop in all heterozygotes. The first step toward leu- 
kemic transformation occurs within the maturing thy- 
mocyte population and is demarcated by clonal expan- 
sions and loss of the single lkaros wild-type allele. 
From thesestudies, we proposethat within developing 
and mature T lymphocytes, distinct thresholds of 
lkaros activity are required to regulate proliferation. 
A decrease in lkaros activity below the first threshold 
causes the rapid accumulation of T lymphoblasts, 
whereas a further decrease leads to neoplastic trans- 
formation. 
Introduction 
Thelkarosgene encodes, by means of differential splicing, 
six lymphoid-restricted zinc finger proteins that are differ- 
entially expressed in the developing hemolymphopoietic 
system of mice and humans (Georgopoulos et al., 1992; 
Molnar and Georgopoulos, 1994; Molnar et al., 1995). The 
lkaros isoforms differ in their N-terminal zinc finger compo- 
sition and in their overall DNA binding and transcriptional 
activation properties. Of the lkaros proteins, which contain 
from two to four zinc finger modules at their N-terminal 
region, four bind DNA differentially and display distinct 
transcriptional activation and nuclear localization proper- 
ties (Molnar and Georgopoulos, 1994). The two lkaros pro- 
teins with fewer than two N-terminal zinc fingers cannot 
bind DNA with high affinity and do not activate transcrip- 
tion (Molnar and Georgopoulos, 1994). All of the lkaros 
isoforms share two C-terminal zinc fingers that mediate 
their self-association (Sun et al., submitted). The20 homo- 
and heteromeric complexes that can form among the 
lkaros isoforms are expected to differ in their DNA binding 
and transcriptional activation properties. Therefore, the 
lkaros gene may regulate multiple layers of gene expres- 
sion in developing lymphocytes. 
We have recently shown that the lkaros gene, which is 
abundantly expressed during early fetal hemopoiesis and 
prior to the appearance of identifiable lymphoid progeni- 
tors, is essential for development of the lymphopoietic sys- 
tem in the mouse (Georgopoulos et al., 1992, 1994). Mice 
homozygous for a mutation in the lkaros DNA-binding do- 
main lack not only mature Tand B lymphocytes and natural 
killer (NK) cells, but also their earliest identifiable progeni- 
tors (Georgopoulos et al., 1994). The complete absence 
of defined lymphoid progenitors in these lkaros mutant 
mice confirms a crucial role for lkaros at the very early 
stages of development of the murine lymphopoietic 
system. 
lkaros is also expressed at prominent levels throughout 
the ontogeny of the T lineage, in both the fetus and adult, 
suggesting that it is also required at the later stages of 
lymphoid development (Georgopoulos et al., 1992). T cell 
differentiation proceeds through a series of maturation 
steps tightly coupled to sequential rearrangements that 
assemble the T cell receptor (TCR) genes (Mombaerts et 
al., 1992a, 1992b; Shinkai et al., 1992; Godfrey et al., 
1994). Engagement of the pre-TCR complex on the surface 
of immature double-negative (CD4-CD8-) thymocytes trig- 
gers their clonal expansion and subsequent differentiation 
to a double-positive (CD4+CD8+) stage (reviewed by An- 
derson and Perlmutter, 1995). In contrast, engagement of 
the T antigen receptor on CD4’CD8+ thymocytes results 
in either their maturation to a single-positive T cell (CD4+ 
or CD8+) or to their death by apoptosis. At this stage of 
differentiation, maturation occurs without clonal expan- 
sion (Ashton-Rickardt et al., 1993; Hogquist et al., 1994; 
Chan et al., 1993; Vasquez et al., 1994; Takahama et al., 
1994; reviewed by Janeway, 1994). 
The following studies on the lymphopoietic system of 
lkaros heterozygous mice clearly demonstrate that the 
lkaros gene is not only required for the first step(s) in 
lymphoid lineage specification, but is also a necessary 
factor during later stages of T cell maturation. Mice hetero- 
zygous for the previously described lkaros mutation, with 
normal lymphocyte cell surface antigen phenotypes dur- 
ing the first month of their lives, undergo dramatic changes 
in their T cell populations shortly afterward. A general 
lymphoproliferation is detected in the thymus and periph- 
ery that precedes the T cell leukemia and lymphoma that 
invariably develop in these mice. Clonal expansion of T 
lymphocytes is first detected in the thymus, implicating 
maturing thymocytes as the target population for neoplas- 
tic transformation. These malignant thymocyte clones, 
which replace cell populations in all lymphoid tissues and 
infiltrate all major organs, have lost the single lkaros wild- 
type allele. The onset and progression of lymphoprolifera- 
tive disease in the lkaros mutant mice may be secondary 
to TCR ligation events that take place in the thymus, the 
periphery, or both. In support of this hypothesis, heterozy- 
gous thymocyte populations from 1 -month-old animals, 
which appear phenotypically normal by flow cytometry, un- 
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Figure 1. Thymocyte Profiles of lkaros Heterozygous Mice at 1 and 
2 Months of Age 
Thymocytes from Ikaros heterozygous(+/-) and wild-type control (+I+) 
mice were stained with the following combinations of monoclonal anti- 
bodies: anti-CD4PE-anti-CD8F’TC, anti-CD8PE-anti-TCRu~F1TC, anti- 
CD4PE-anti-TCRa!3F’TC, and anti-CD3PE-anti-CD25F’TC. Percentages of 
cells that fall into each boxed positive population are indicated. 
dergo augmented TCR-mediated proliferative responses 
in vitro, and peripheral T cells are autoproliferative. 
Taken together, these observations clearly demonstrate 
that the lkaros gene is not only a regulator of lymphoid 
lineage specification but also controls T cell proliferative 
responses and homeostasis. Progressive loss of lkaros in 
the T lineage may be coincidental with progressive loss of 
growth control and malignant transformation of maturing 
thymocytes. 
Results 
Lymphocyte Populations in lkaros 
Heterozygous Mice 
Mice heterozygous for the lkaros DNA-binding mutation 
display normal cell surface phenotypes in thymus and 
spleen populations for the first month of their lives (Fig- 
ure 1). The numbers of single-positive (CD4+CD8- and 
CD8+CD4-) and double-positive (CD4+CD8+) thymocytes 
as well as mature splenic T cells (CD4’TCRaB+ and 
CD8+TCRap+) and B cells (CD45R+lgM+) are similar to 
those of their wild-type siblings. Furthermore, the levels 
of expression of T and B cell differentiation antigens (CD4, 
CD8, CD3, CD25, TCRafi, CD45R, and IgM) are normal. 
Bone marrow populations also appear normal in l-month- 
old heterozygotes (data not shown). 
However, between the second and third month of age, 
changes are detected within the thymic compartment. Cell 
intermediates between the CD4+CD8’” and CD4%D8+ 
stage accumulate, and thymocyte populations lose their 
discrete single- and double-positive profiles(Figure 1). The 
majority of these CD4+CD8+ heterozygous thymocytes ex- 
press intermediate levels of the TCR (TCR’“‘) complex. In 
the wild-type thymus, 40% of the CD4+CD8+ population 
expresses low levels of the TCR complex, which becomes 
up-regulated during the process of selection (Chan et al., 
1993). The phenotypically similar triple-positive thymo- 
cytes that accumulate in the heterozygous thymus may 
be derived from the same stage of development as transi- 
tional stage intermediates in the wild-type thymus. A 
2- to 5-fold increase in the number of splenocytes was 
also observed in the 2- to 3-month-old heterozygotes. In 
all cases, this was due to a polyclonal expansion of T 
lymphocytes in the spleen. In some animals, a slight in- 
crease (less than P-fold) in the number of B lymphocytes 
was also observed (data not shown). 
Proliferative Responses of Thymocyte 
and Peripheral T Cells in lkaros 
Heterozygous Mice 
The proliferative responses of lkaros heterozygous thymo- 
cytes and peripheral T cells were determined prior to the 
first changes in thymocyte populations. Thymocytes and 
splenocytes from 1 -month-old lkaros heterozygotes and 
wild-type controls were plated at different concentrations 
in wells coated with an antibody raised to the constant 
region of the TCR complex 0 chain. After 48 hr of TCR 
stimulation, heterozygous thymocytes displayed a dra- 
matic increase in [3H]thymidine incorporation, a measure 
of proliferative response, relative to background (hlgG) 
(Figure 2A). An average 200-fold increase in [3H]thymidine 
incorporation was detected. In sharp contrast, under the 
same conditions, wild-type thymocytes displayed low pro- 
liferative responses (an average 7.7-fold increase in 
[3H]thymidine incorporation over background) (Figure 2A). 
Heterozygous splenocytes proliferated in the absence 
of TCR stimulation (hlgG). The level of [3H]thymidine incor- 
poration was an average 2.6-fold greater than observed 
with wild-type control splenocytes (Figure 28). Upon TCR 
stimulation, heterozygous splenocytes also incorporated 
higher levels of [3H]thymidine than wild-type controls (Fig- 
ure 28). Given, however, the higher background prolifera- 
tion of heterozygous splenocytes, their average stimula- 
tion index was similar to wild type. An average 27- and 
35-fold increase in [3H]thymidine incorporation relative to 
background was detected with wild-type and heterozygote 
splenocytes, respectively (Figure 2B). These differences 
in proliferative responses of heterozygous and wild-type 
splenic T cells cannot be accounted for by differences in 
the absolute numbers of T cells in these organs that, on 
average, were similar (data not shown). 
To determine whether the abnormal proliferative re- 
sponse to TCR stimulation observed in the l-month-old 
thymus was a property of the maturing CD4+CD8+ popula- 
tion, we tested embryonic day 17.5 thymocytes. At this 
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Figure 2. Proliferative Responses of lkaros Heterozygote Thymocyte 
and Splenic T Ceils 
Proliferative activity of thymocytes (A) and splenocytes (B) from 
1 -month-old Ikaros heterozygote (+I-) and wild-type (+I+) mice as well 
as embryonic day 17.5 thymocytes (C) as represented by counts per 
minute (cpm) of [3H]thymidine incorporated in response to plate-bound 
anti-TCRab or hamster IgG isotype control antibody (considered back- 
ground). For (A) and (B), results of five independent experiments are 
shown, with each value representing the mean of triplicate cultures. 
Number of cells per culture ranged from 2 x IO5 to 4 x 105. For(C), 
results from a single experiment are shown, with each value represent- 
ing the mean of duplicate cultures with IO5 cells per culture. 
stage in fetal development, thymocytes exist as a homoge- The phenotype of lymphocyte populations in affected 
neous CD4+CD8+ population with no detectable single- lkaros heterozygous mice was determined by flow cytome- 
positive cells. These CD4+CD8+ fetal thymocytes are in try. Cells obtained from thymus, lymph nodes, spleen, and 
the process of completing TCR rearrangements, and a bone marrow of these animals were analyzed with antibod- 
subfraction of these cells, approximately 10% as deter- ies to a number of early and late lymphocyte differentiation 
mined by flow cytometry (data not shown), express low markers. The accumulating lymphocytes in all lymphoid 
levels of TCRa8. Heterozygous fetal thymocytes also dis- organs, including the bone marrow, were T cells. These T 
played higher levels ~f[~H]thymidine incorporation relative 
to thymocytes from their wild-type siblings (Figure 2C). 
However, the magnitude of the proliferative response of 
heterozygous fetal thymocytes was less dramatic than that 
observed with the l-month-old heterozygous thymocytes, 
perhaps owing to the lower percentage of TCR+ cells in 
the embryonic day 17.5 thymus. 
Leukemia and Lymphoma Invariably Develop in 
Ikaros Heterozygous Mice 
Soon after 3 months of age, 100% of lkaros heterozygous 
mice develop visible lymphadenopathy. Cervical, axial, 
and mesenteric lymph nodes are grossly enlarged to 20- 
50 times the normal size (Figure 3A). The spleen is the 
predominant organ in the abdominal cavity, and there is 
an average lo-fold increase in the number of splenocytes 
(Figure 38). The thymus is also enlarged and shows loss 
of its distinctive bilobed morphology (Figure 3C). Oblitera- 
tion of the normal architecture of lymphoid organs is 
caused by accumulation of a uniform population of lym- 
phoblastic lymphocytes (Figure 4). Complete effacement 
of the cortical-medullary structures is observed in the thy- 
mus (Figures 4C and 4D). Increase in the white pulp and 
decrease in the red pulp areas of the spleen are consis- 
tently observed (Figures 4A and 4B). B fymphoid follicles 
as well as cortical and medullary regions are absent in 
the lymph nodes (data not shown). A dramatic increase 
in the number of circulating lymphocytes is also seen in 
the peripheral blood of these animals (Figure 4E). These 
cells are lymphoblastic in appearance, having large nuclei 
with fine chromatin structure, prominent nucleoli, and 
scanty cytoplasm. Nonlymphoid organs are also exten- 
sively infiltrated. Histological examination of liver, kidney, 
and lung sections revealed complete effacement of their 
normal tissue architecture by accumulating numbers of 
lymphoblastic cells (Figure 5). 
The lymphoproliferative syndrome and the leukemia 
and lymphoma occur at the same frequency in heterozy- 
gous animals derived from two independent embryonic 
stem cell lines carrying the same lkaros mutation (Georgo- 
poulos et al., 1994). Significantly, chimeric animals with 
moderate to high levels of lkaros embryonic stem cell con- 
tribution also develop this disease, but with an approxi- 
mately 2-month lag period compared with the heterozy- 
gous population. Development of leukemia and lymphoma 
in two lines of lkaros heterozygous mice as well as in lkaros 
chimeras proves the hypothesis that the underlying mech- 
anism is mediated by the lkaros mutation. 
A Homogeneous Population of T Cells with a Mature 
and Activated Phenotype Predominates in All 
Lymphoid Organs 
Cdl 
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Figure 3. Physical Hallmarks of the Lymphoproliferative Syndrome in 
lkaros Heterozygous Mice 
Lymphadenopathy of the inguinal lymph node (A), splenomegaly (B), 
and thymus enlargement (C) in a >3-month-old kafos heterozygote 
with visible manifestations of lymphoproliferative syndrome. 
cells were large (as determined by forward scatter profiles: 
data not shown) and expressed the CD3-TCRa8 complex 
(Figure 6). Coreceptor composition of the accumulating 
T cell population was uniform within a given animal, but 
differed among mice (MU1 and MU2 in Figure 6). 
CD8+TCR+ populations arose with the highest frequency 
(14 of 23 animals), but CD4+TCR+ (2 of 23 animals), 
CD4+CD8+TCR+ (4 of 23 animals), and CDCCD8-TCR+ 
(3 of 23 animals) populations were also detected. 6 cell 
populations were not detectable in the spleen, lymph 
nodes, or bone marrow of affected animals. A relative de- 
crease in size of the erythroid and myeloid compartments 
of the spleen and bone marrow was also seen (Figure 6B; 
data not shown). 
Of the aberrant T cell population, 5%-l 00% expressed 
the CD25 (interleukin-2 [IL-21 receptor a chain) activation 
marker (Figure 6). A higher percentage of CD25+ cells 
within the population strongly correlated with later stages 
of the disease. These aberrant T cell populations could 
be propagated indefinitely in vitro in the presence of IL-2. 
In several cases, they grew in the absence of added growth 
factors. 
The Aberrant T Cell Populations Are Clonal 
in Nature and Arise in the Thymus 
Since all of the aberrant T cell populations analyzed ex- 
pressed the TCRab complex, their clonality was studied 
by examining TCR composition. This analysis was under- 
taken in two ways. The structure of the TCR j3 chain gene 
was investigated by determining the D8 to Jj3 segment 
rearrangments in these T cell populations (Anderson et 
al., 1992). In addition, Vf3 specificity was studied by flow 
cytometry. 
Seven D82-Jf32 rearrangements and one band corre- 
sponding to the germline configuration of the 6 chain gene 
were detected in thymocytes and splenocytes from wild- 
type and l-month-old lkaros heterozygous mice. These 
results reflect the normally polyclonal nature of thymocyte 
and mature T cell populations in these organs (Figure 7A, 
lanes l-4). The differences in the D82-J82 composition 
detected between thymus and spleen reflect differences 
in the residing cell populations. The increased intensity 
of the band corresponding to the germline configuration 
at the 6 chain locus in the spleen is due to the presence 
of the non-T cell populations within thisorgan. In contrast, 
T cell populations in older lkaros heterozygous mice dis- 
played one or two predominant Dj32-Jf32 rearrangements 
that were the same in both the thymus and the spleen (>3 
months in lanes 11-18 of Figure 7A). 
Surface TCR VP expression was studied using a panel 
of monoclonal antibodies specific for TCR VP regions. In 
two representative cases, shown in Figure 7B, the majority 
of T cells were of a single V6 specificity. In one animal, 
90% of the T cell population in the thymus and the spleen 
expressed Vf35.1, V85.2, or both, whereas in a second 
animal, where only spleen cells were analyzed, 80% of 
the cells expressed Vf311. In a third animal, aberrant T 
cell populations in thymus and spleen expressed V63 (data 
not shown). Taken together, these results demonstrate a 
clonal origin for these aggressively growing T cell popula- 
tions. 
To determine the origin of these malignant T cell clones, 
we analyzed lymphocyte populations in 2- to 3-month-old 
lkaros heterozygotes without visible manifestations of 
lymphoproliferation prior to dissection. The repertoire of 
D82-J62 rearrangments in the thymus and spleen was 
again studied. Outgrowth of clonal T cell populations, man- 
ifested as a decrease in the repertoire of D82-J82 rear- 
rangments, was apparent in the thymus (T in lanes 5, 7, 
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and 9 of Figure 7A) but not in the spleen (S in lanes 6, 8, 
and 10 of Figure 7A). These results suggest a thymic origin 
for the malignancies. 
Clonal T Cell Populations from lkaros Heterozygous 
Mice Readily Form Tumors in Nude Mice 
T ceils isolated from the thymus of an lkaros heterozygote 
with leukemia and lymphoma were injected subcutane- 
ously into mice of the nude/beige background. The first 
signs of local tumor outgrowth were seen during the first 
week postinjection. By the third week, tumors grew to 
2-3 cm in diameter (Figure 7C). At this point, animals 
were sacrificed, and tumors (as well as, in some cases, 
spleen, bone marrow, and lymph node populations) were 
analyzed by flow cytometry. Cells isolated from the tumors 
were of the same cell surface phenotype (CD4-CD8- 
TCRap+CD25+) as the injected T cells and displayed the 
same single D/32-Jb2 rearrangement (data not shown). 
This same T cell population predominated in the spleen, 
lymph nodes, and bone marrow of these nude mice. The 
ability of aclonal Tcell population from an lkaros heterozy- 
gote to readily form tumors upon adoptive transfer and 
to invade and replace the normal cell populations in the 
lymphoid organs of the host clearly proves its malignant 
nature. 
Loss of lkaros Heterozygosity in the Malignant 
T Cell Clones 
We next determined whether expression of lkaros iso- 
forms generated by the wild-type or mutant alleles was 
Figure 4. Complete Effacement of Tissue Ar- 
chitecture in Lymphoid Organs of lkaros Het- 
erozygous Mice 
(A-D) Hematoxylin- and eosin-stained tissue 
sections from spleen and thymus of lkaros het- 
erozygotes (+I-) (B and D) and wild-type con- 
trol mice (+/+) (A and C). Magnification, 30x. 
Abbreviations: r, red pulp: w, white pulp; m, 
medulla; c, cortex. 
(E) Wright-Giemsa-stained peripheral blood 
smear from an lkaros heterozygote with inset 
showing higher magnification of a circulating 
lymphoblast. 
altered in the lymphoid populations of the healthy and dis- 
eased heterozygous mice. Reverse transcription polymer- 
ase chain reaction (FIT-PCR) was used to study expres- 
sion of lkaros wild-type and mutant messages in the 
thymus and the spleen of l- to 3-month-old animals, as 
previously described (Molnar and Georgopoulos, 1994). 
lkaros transcripts generated from both the mutant and 
wild-type alleles were detected in the thymus and spleen 
of l-month-old heterozygous mice (Figure 8A, lanes 3 and 
4). However, only transcripts derived from the lkaros mu- 
tant allele were detected in lymphoid organs from hetero- 
zygous mice with leukemias and lymphomas and cells 
from a nude mouse tumor (Figure 8A, lanes 10-15). To 
exclude the possibilitythat this result was due to preferen- 
tial amplification of the shorter mutant cDNAs, we used 
a different set of primers that amplified only wild-type 
cDNAs. No amplification products were detected with 
these primers, proving that wild-type lkaros messages 
were not expressed in these malignant T cells (data not 
shown). Lack of wild-type lkaros transcripts was first de- 
tected in the thymus of 2- to 3-month-old heterozygotes 
(Figure 8A, lanes 5 and 8), while the spleen and bone 
marrow of these mice expressed both the wild-type and 
mutant forms (Figure 8A, lanes 6,7, and 9). This apparent 
lack of thymic expression from the lkaros wild-type allele 
was coincidental with the accumulation of clonal T cell 
populations in this organ (see Figure 7A, lanes 5-10). 
Studies of lkaros protein expression in these cells con- 
firmed these results (data not shown). 
To determine whether the lkaros wild-type allele was 
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Figure 5. Invasion of Nonlymphoid Organs by Lymphoblastic Cells 
Hematoxylin- and eosin-stained tissue sections from kidney (A), liver 
(B), and lung (C) of lkaros heterozygotes with lymphoproliferative syn- 
drome. Magnification, 82 x 
still intact, we used Southern blot analysis to study the 
structure of the lkaros loci. A single 13.5 kb BamHl frag- 
ment, derived from the mutant lkaros locus, was detected 
when DNAs from the thymus of mice with leukemia and 
lymphoma were analyzed (Figure 88, lanes 3, 5, and 9). 
This mutant genomic fragment was also predominant in 
DNAs prepared from the spleen of these animals (Figure 
88, lanes 4,6, and 10). The low levels of the 18.5 kb BamHl 
fragment, derived from the wild-type locus, detected in the 
spleen can be accounted for by the erythroid and myeloid 
cells, present as minor populations in this organ. Loss of 
the wild-type lkaros allele was also evident in cells from 
a nude mouse tumor (Figure 8B, lane 11). However, in a 
3-month-old heterozygote with polyclonal thymocyte and 
splenocyte populations (see Figure 7A, lanes 9 and lo), 
wild-type and mutant lkaros alleles were detected at simi- 
lar levels (Figure 88, lanes 7 and 8). 
Discussion 
A targeted deletion in the lkaros DNA-binding domain 
leads to an early arrest in lymphocyte development in mice 
homozygous for the mutation. Mice heterozygous for this 
lkaros mutation display initially normal lymphocyte pro- 
files. Therefore, the lack of one wild-type lkaros allele and 
the presence of one mutant do not prevent early develop- 
ment in the T and B cell lineages. 
However, phenotypically normal thymocyte populations 
in lkaros heterozygous mice exhibit strong TCR-mediated 
proliferative responses. In sharp contrast, thymocytes 
from wild-type mice respond weakly when triggered in this 
way. Since levels of expression of the TCR and coreceptor 
complexes appear to be similar between healthy lkaros 
heterozygous and wild-type thymocytes, signaling down- 
stream of the TCR complex must be deregulated in these 
cells. Temporal engagement of the TCR complex is neces- 
sary to drive thymocytes through distinct stages in differ- 
entiation (reviewed by Anderson and Perlmutter, 1995). 
Engagement of the pre-TCR complex on CD4-CD8- thy- 
mocytes mediates their clonal expansion and differentia- 
tion to the CD4+CD8+ stage. In contrast, differential cross- 
linking of the TCR complex on the surface of a CD4+CD8+ 
thymocyte mediates either cell death by apoptosis (nega- 
tive selection) or maturation to the single-positive stage 
without expansion (positive selection). Which fate awaits 
a triggered thymocyte, survival or death, may depend on 
signals transduced through different effector molecules. 
Signaling pathways similar to those that operate during 
activation of a mature T cell have been proposed to medi- 
ate this process (Sloan-Lancaster et al., 1994; Madrenas 
et al., 1995; Vasquezet al., 1994). Deregulated expression 
or activity of signaling molecules may underlie the aug- 
mented proliferative responses of lkaros heterozygous 
thymocytes. 
Changes in thymocyte populations are detected prior 
to any change in expression of lymphocyte cell surface 
antigens in the periphery. Intermediate CD4+CD8+ cells 
expressing the TCR complex (CD4+CD8’0TCRin’ and 
CD8+CD4”‘TCRint) become the predominant populations. 
Intermediate thymocyte populations, present in small 
numbers in the wild-type thymus, are considered to be 
cells in transition to the single-positive stage and in the 
process of selection (Chan et al., 1993; Fischer et al., 
1995). During normal maturation of CD4+CD8+ thymo- 
cytes, up-regulation of theTCR complex with concomitant 
down-regulation of one of its coreceptors takes place 
(Chan et al., 1993; Davis et al., 1993; reviewed by von 
Boehmer and Kisielow, 1993). Cells with inappropriate 
TCR expression are destined to die by apoptosis (reviewed 
by Janeway, 1994). Deregulation of the process that con- 
trols transition from the double- to the single-positive stage 
may lead to the accumulation of CD4+CD8+ thymocyte 
intermediates in lkaros heterozygous mice. Additional ge- 
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Figure 6. Flow Cytometric Analysis of Lymphoid Organs in lkaros Heterozygotes with Lymphoproliferative Disorder 
Profiles of thymocyte (A) and splenocyte (6) populations of two lkaros heterozygotes displaying distinct coreceptor phenotypes (MUl, CDB+CD4-; 
MU2, CD8+CD4+). Profiles of cells in bone marrow and lymph node(C) from MU1 are also shown. Cells were stained with the following combinations 
of monoclonal antibodies: anti-CD4PE-anti-CD8F’Tc, anti-CD8PE-anti-TCRa6F1TC, anti-CD4PE-anti-TCRaf3F’Tc, and anti-CD3PE-anti-CD25F’“. Percent- 
ages of cells that fall into each boxed positive population are indicated. 
netic events (i.e., loss of the second lkaros allele) in this 
cell population may lead to their transformation. 
Peripheral T cells in l-month-old lkaros heterozygous 
mice also display aberrant proliferative properties. Splenic 
T cells autoproliferate when cultured in vitro and, when 
stimulated through the TCR complex, display higher levels 
of [3H]thymidine incorporation than wild-type control cells. 
This may be due to an accumulation of autoimmune T 
cells in the periphery caused by a breakdown in the thymic 
selection process. Aberrant proliferation of nontrans- 
formed heterozygous peripheral T cells, together with a 
potential impairment in the death pathways that mediate 
elimination of activated Tcells, may account for the moder- 
ate increase in size of the spleen detected in the 2- to 
3-month-old heterozygotes. This polyclonal T cell prolifer- 
ation precedes the clonal expansion of malignant T lym- 
phocytes responsible for the massive size increase of the 
spleen in the older heterozygous mice. 
Between 3 and 6 months of age, 100% of lkaros hetero- 
zygous mice develop fatal leukemia and lymphoma. Malig- 
nant lymphoblastic T cells replace the normal cell popula- 
tions in lymphoid tissues. However, outgrowth of clonal T 
cell populations is first detected in the thymus, in support 
of the hypothesis that the targets for transformation are 
thymocytes undergoing inappropriate proliferative re- 
sponses during their transition from the double- to the sin- 
gle-positive stage. Although all of the aberrant Tcell clones 
express the CD3-TCRa8 complex, distinct TCR specifici- 
ties emerge in different animals, suggesting that the trans- 
formation event is stochastic. The CD25 (IL-2 receptor a 
chain) activation marker is also expressed on these lym- 
phoblastic T cells, but the percentage varies among ani- 
malsand is highest in laterstagesofthediseaseasdefined 
by a complete takeover of lymphoid organs by clonal 
lymphoblastic T cells. Expression of the CD25 activation 
marker on the surface of these cells suggests that perhaps 
an autocrine pathway has been activated in these cells 
that supports their autonomous growth, as has been re- 
ported in some cases of human leukemia (Gootenberg 
et al., 1981). The autonomous growth and tumorigenic 
properties of these malignant T cells were confirmed by 
adoptive transfer. Lymphoid tumors containing cells with 
the same cell surface phenotype and genetic make-up as 
the input cells were formed shortly after transfer into nude 
mice. 
Genetic analysis of T cell leukemias and lymphomas in 
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Figure 7. Aberrant T Cell Populations in lkaros Heterozygotes Are 
Clonal in Origin and Have Evaded Growth Control 
(A) PCR analysis of D82-J82 rearrangements using genomic DNAs. 
Expected PCR product for germline configuration is 1856 bp and for 
rearrangements of D82.1 to either J82.1, J62.2, Jf32.3, Jb2.4, J62.5, 
J82.6, or J82.7 are between 1279 and 224 bp. All amplified PCR prod- 
ucts hybridized with an internal oligonucleotide probe, confirming their 
specificity (data not shown). DNAs analyzed were from the thymus 
and spleen of a wild-type animal (lanes 1 and 2) a 1 -month-old hetero- 
zygote (lanes 3 and 4), three 2- to 3-month-old heterozygotes (lanes 
5-10) four >3-month-old heterozygotes with visible lymphoprolifera- 
tive disorder (lanes 1 l-l 6). Abbreviations: S, spleen; T, thymus. Mo- 
lecular weight markers on the left are a 1 kb DNA ladder (GIBCO BRL). 
(6) Flow cytometric analysis of V6 usage in the thymocyte and spleno- 
cyte populations of one lkaros heterozygote (top) and the splenocyte 
population of a second heterozygote (bottom). Open histograms repre- 
sent staining with isotype control antibodies. 
(C) Nude mouse with a tumor developed approximately 3 weeks post- 
subcutaneous injection of 2 x lo6 thymocytes from a >3-month-old 
affected heterozygote. 
the lkaros heterozygous mice revealed loss of the wild- 
type lkaros allele in these cells. Karyotypic analysis dis- 
played a normal complement of chromosomes (data not 
shown). Therefore, the loss of the wild-type lkaros allele is 
either due to illegitimate mitotic segregation of two mutant 
chromatids, to a gene conversion event, or to a deletion 
of the lkaros gene. In any case, loss of the wild-type lkaros 
allele may be directly linked to the malignant transforma- 
tion of heterozygous thymocytes. Alternatively, loss of 
lm 2m 3m >3m 
4-Fu-4-e- U$ 
B t -I4 
+/- 
* 
t ITST STSTS Turn 
1 2 3 4 5 6 7 8 9 IO 11 
Figure 8. Loss of lkaros Heterozygosity in Transformed T Lympho- 
cytes 
(A) RT-PCR analysis of lkaros transcripts expressed in the lymphoid 
organs of lkaros heterozygotes (top). Expected sizes of products are 
as follows: Ik-1, 750 bp; lk-2, 490 bp; lk-4, 365 bp; mutant Ik-1 and 
lk-2, 325 bp; and mutant lk-4, 200 bp (as described by Georgopoulos 
et al., 1994). cDNAs analyzed were from thymus, spleen, and bone 
marrow of a 1 -month-old wild-type animal (lanes 1 and 2), a 1 -month-old 
heterozygote (lanes 3 and 4) a amonth-old heterozygote (lanes 5-7) 
a 3-month-old heterozygote (lanes 8-l I), a nude mouse T cell tumor 
(lane 15), an lkaros homozygote (lane 16)‘ and a no DNA control (lane 
17). Abbreviations: S, spleen; T, thymus; EM, bone marrow; Turn, 
tumor. Cells from thymus, spleen, and bone marrow of four animals 
older than 3 months with visible physical manifestations of lymphopro- 
liferative disorder were pooled (P). The bottom panel shows the results 
of PCR analysis of these same cDNAs with primers that amplify se- 
quences of the ubiquitously expressed housekeeping gene GAPDH. 
(B) lkaros gene structure in lymphoid tissue from lkaros heterozygotes. 
DNAs were prepared from a wild-type animal (lane l), an lkaros homo- 
zygote (lane 2) >3-month-old lkaros heterozygotes with visible physi- 
cal manifestationsof lymphoproliferativedisorder(lanes3-6and 9 and 
lo), a 3-month-old heterozygote with polyclonal lymphoproliferation 
(lanes 7 and 6), and a nude mouse T cell tumor (lane 11) and were 
digested with BamHl and analyzed by Southern blotting. Abbrevia- 
tions: S, spleen; T, thymus; Turn, tumor. An 870 bp genomicfragment 
was used as a probe to analyze the 5’ end of the targeted region in 
the Ikaros locus (as described by Georgopoulos et al., 1994). The 
18.5 and 13.5 kb BamHl fragments are derived from the wild-type and 
mutant lkaros alleles, respectively. 
lkaros heterozygosity may confer a growth advantage to 
these cells that may undergo additional genetic events 
before they transform. Loss of heterozygosity in cells with 
mutations in the p53 and retinoblastoma tumor suppressor 
genes is also coincidental with their progression to a tu- 
morigenic state (Cavenee et al., 1983; Dryja et al., 1986; 
Friend et al., 1986; Fung et al., 1987; Lee et al., 1987). 
lpr and g/d mice also develop lymphoproliferative syn- 
dromes. Polyclonal proliferation of CD4-CD8-TCWTcells 
was described in the peripheral lymphoid organs of these 
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Figure 9. Loss of lkaros Wild-Tvoe Alleles in the Developina Hemolvmphopoietic System Reveals Distinct Roles for the Gene in Lymphoid Lineage 
Specification and T Cell Homebstasis 
- 
mice. However, these lymphocytes are not transformed 
(Andrews et al., 1978; Cohen and Eisenberg, 1991; Roths 
et al., 1984; Wayne et al., 1994). In the case of lpr and 
g/d mice, mutations in the Fas gene or its ligand impair 
the process of apoptosis that operates in the periphery to 
eliminate T cell lymphoblasts generated during an immune 
response (Russell and Wang, 1993; Russell et al., 1993). 
Fas expression, which is normal in the thymus of 1 -month- 
old heterozygous mice, is down-regulated in the thymus 
of 2-month-old lkaros heterozygotes (data not shown). Low 
levels of Fas expression may reflect the phenotype of tran- 
sitional CD4+CD8+ intermediates that represent a minor 
population in the wild-type thymus but that predominate 
in the 2-month-old heterozygous organ. Alternatively, de- 
regulation of Fasexpression in these heterozygous thymo- 
cytes may cause their inability to die by apoptosis and 
may be a necessary step that leads to their transformation. 
The lkaros gene is therefore required for both early and 
late events in lymphocyte differentiation (Figure 9). Loss 
of lkaros activity at different stages of this developmental 
process has dramatically different effects. Lack of lkaros 
activity in an early hemopoietic progenitor prevents its 
commitment to the lymphoid lineage (Figure 9). In sharp 
contrast, loss of lkaros activity at the late stages of T cell 
maturation strongly correlates with T cell transformation 
(Figure 9). In addition, thymocytes and mature T cells 
heterozygous for this lkaros mutation are not functionally 
normal. Thymocytes display augmented TCR-mediated 
proliferative responses, and peripheral Tcells are autopro- 
liferative. Excessive lymphoproliferation in these lympho- 
cyte populations may increase the number of cells avail- 
able to undergo leukemic transformation by loss of the 
second lkaros wild-type allele. However, our results show 
that loss of lkaros heterozygosity and malignant transfor- 
mation are events that take place in the thymus, not in 
the periphery, suggesting that the lkaros mutation has 
qualitatively different effects on the growth of immature 
thymocytes versus mature peripheral T cells. 
Distinct thresholds of lkaros activity may be required 
at different stages of lymphocyte development. A higher 
threshold of lkaros activity, compared with that required 
in lymphoid progenitors and mature lymphocytes, may be 
essential for the regulated proliferation of developing thy- 
mocytes. This hypothesis is consistent with the higher lev- 
els of lkafos mRNAs detected in maturing thymocytes rela- 
tive to peripheral T and B cells in both mouse and human 
(Georgopoulos et al., 1992; Molnar et al., 1995). We have 
recently shown that the C-terminal zinc fingers in the 
lkaros proteins mediate their self-association and modu- 
late their DNA binding and transcriptional activation poten- 
tial (Sun et al., submitted). Proteins generated from the 
lkaros mutant allele may, therefore, act in a dominant neg- 
ative fashion by sequestering wild-type isoforms in hetero- 
dimers with altered DNA-binding properties. Complex for- 
mation between wild-type and mutant lkaros proteins 
interferes with the ability of the formerto activate transcrip- 
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tion (Sun et al., submitted). Owing to the formation of wild- 
type and mutant lkaros complexes in heterozygous lym- 
phocytes, the concentration of lkaros wild-type complexes 
is expected to decrease to one fourth that present in wild- 
type cells. Such a profound decrease in lkaros wild-type 
complexes does not interfere with lymphocyte develop- 
ment but may dramatically affect lymphocyte homeosta- 
sis. Significantly, the appearance of malignant T cell clones 
among the lkaros heterozygous thymocytes strongly cor- 
relates with loss of lkaros heterozygosity and could be 
interpreted either as a result of complete loss of lkaros 
DNA-binding activity or a gain of function attributed to the 
mutant lkaros proteins. 
The wild-type lkarosallele encodes splicing variants that 
structurally resemble the mutant proteins in that they lack 
the N-terminal DNA-binding domain (lk-5 and lk-6). These 
variants are expressed at very low levels in wild-type lym- 
phocytes (Molnar and Georgopoulos, 1994; our unpub- 
lished data). Short lkaros isoforms may interact with fac- 
tors that control proliferative responses in developing 
thymocytes and mature T cells. Deregulated expression 
of these normally expressed proteins may result in a phe- 
notype similar to that observed in the heterozygotes: T 
cell hyperproliferation and malignant transformation. 
From these studies on lkaros heterozygous mice, we 
conclude that the lkaros gene is an essential regulator 
for both lymphoid lineage specification and subsequent 
proliferation and differentiation in the T lineage. Lack of 
lkaros activity at the late stages of thymocyte maturation 
leads to uncontrolled lymphoproliferation and to the rapid 
development of malignant Tcell leukemia and lymphoma. 
Experimental Procedures 
Histological Analysis of lkaros Mutant Mice 
Tissues harvested from euthanized wild-type and lkaros mutant mice 
werefixed in 4% bufferedformalin, processed, and embedded in paraf- 
fin. Sections were cut at 5 pm thicknesses, mounted, and stained with 
hematoxylin and eosin. Light microscopy was performed at 20 x to 
600x magnification on an Olympus BMax-50 microscope. 
Cytofluorometry of Hemopoietic Cell Populations 
lkaros heterozygote mutant mice were analyzed in parallel with age- 
matched wild-type controls. Animals on mixed background were stud- 
ied (129/Sv x C57BU6 and 1291s~ x BALBlc). Lymphocytes from 
the thymus, spleen, lymph nodes, and bone marrow were prepared as 
described previously (Georgopoulos et al., 1994). Cells were washed 
twice in complete media (RPM1 1640 supplemented with 10% fetal 
calf serum, 2 mM L-glutamine, 5 x 10e5 M !3-mercaptoethanol, and 
50 pglml gentamicin), counted, and resuspended at approximately 
0.5 x lo6 to 1 x 10” cells per 30 ~1. Cells were aliquoted into 96-well 
plates (30 pl per well) and blocked with an equal volume of a 1:20 
dilution of normal rat serum in PBS for 30 min on ice followed by 
incubation with phycoerythrin (PE)- and fluorescein isothiocyanate 
(FITC)-conjugated monoclonal antibodies for 30 min. Cells were then 
washed three times, fixed (1% paraformaldehyde, 0.5% BSA, and 
0.05% sodium azide in PBS), and stored at 4%. We performed one- 
and two-color flow cytometric analyses on a FACScan (Becton- 
Dickinson). Isotype-matched control antibodies were used as negative 
controls; 5 x 1 O3 to 1 x 104cells were analyzed for each sample. The 
following antibodies (in parentheses) to lineage-specific differentiation 
antigens were used (antibodies were obtained from PharMingen un- 
less otherwise indicated): erythroid (TER-119), Mac-i (M1/70.15; Cal- 
tag), Gr-1 (RB6-8C5), CD45R (RA3-6B2), IgM (R6-60.2), CD8 (53-6.7 
and 53-5.8), CD3s (145-2Cll), CD4 (RM4-4), CD25 (7D4), TCRaP 
(H57-597), VB2 (B20.6), VB3 (KJ-25), Vg5.1 and VB5.2 (MR9-4), VP8 
(RR4-7), Vg8.1 and VB8.2 (MR5-2), VP9 (MRlO-Z), VP10 (B21.5), VP1 1 
(RR3-15), Vp12 (MRil-I), VB13 (MR12-3), VP14 (14-2), and VP17a 
(KJ-23). 
Proliferative Responses of Thymocytes and Splenocytes to 
TCR Cross-Linking 
Flat-bottomed 96-well microtiter plates were coated with 20 pglml anti- 
TCRab monoclonal antibody (H57-597; PharMingen) or hamster IgG 
isotype control antibody (PharMingen) overnight at 4%. Organs were 
removed aseptically from lkaros heterozygotes and wild-type age- 
matched control animals, and single-cell suspensions were made as 
described above. Cells were plated at two different cell concentrations 
(0.5 x 1 O5 to 4 x lo5 cells per well) in triplicate in RPM1 1640 supple- 
mented with 10% fetal calf serum, 2 mM L-glutamine, 5 x 1O-5 M 
@-mercaptoethanol, and 50 vg/ml gentamicin. For embryo studies, lo5 
cells per well were plated in duplicate. After 48 hr, cells were fed and 
then pulsed for 6-12 hr with 2 &i of [3H]methylthymidine per well. 
Cells were then transferred to a filter using an automatic cell harvester 
(Harvester 96; TomTec) and counted on the 1205 Betaplate scintilla- 
tion counter (Wallac). 
PCR Analysis of TCR Gene Structure 
DNAs were prepared from thymocytes and splenocytes as previously 
described (Laird et al., 1991). PCR was carried out as described by 
Rodewald et al. (1994) with the following modifications. Samples were 
denatured (94OC for 45 s), annealed (63% for 45 s), and extended 
(72% for 1 min) for 35 cycles. Aliquotsfrom each sample were electro- 
phoresed on a 1.2% agarose Tris-borate-EDTA gel and blotted onto 
a Hybond N+ (Amersham) membrane in 0.4 M NaOH. Sequences of 
synthetic oligonucleotides (5’to 3’) used as primers (Dj32.1 and JB2.7) 
and as an internal probe (DPINT) for Southern blot analysis are as 
follows: DB2.1, GTA GGC ACC TGT GGG GAA GAA ACT; Jp2.7, TGA 
GAG CTG TCT CCT ACT ATC GAT T; DBINT, ATT GTG GGG ACT 
GGG GGG GC. 
In Vivo Tumor Induction 
Thymocytes were prepared aseptically, as described previously, from 
a >3-month-old heterozygote with lymphoproliferative syndrome and 
from a wild-type control mouse. Cells were injected subcutaneously 
into nude mice of the N:NIH-bg-nu-xid BR background (Charles River 
Laboratories). Mice were divided into three groups of five animals 
each. One group received 2 x lo6 heterozygote thymocytes, the sec- 
ond 6 x 1 O6 heterozygote thymocytes, and the third 6 x lo6 wild-type 
thymocytes. Cell surface phenotype was determined by staining with 
the following combinations of monoclonal antibodies: anti-CD4PE-anti- 
CDBFITC, anti-CD8PE-anti-TCRapF’TC, anti-CD4PE-anti-TCRapF1TC, and 
anti-CD3PE-anti-CD25F’TC, as described above. 
Genomic Southern Blots 
DNA was prepared from thymocytes and splenocytes as described 
above. Digestions were performed with BamHl overnight at 37%. 
Samples were electrophoresed on a 0.5% agarose Tris-borate-EDTA 
gel overnight at 50 V and transferred to a Hybond N+ (Amersham) 
membrane. Filters were probed with an 870 bp fragment consisting 
of intronic sequences between exons 2 and 3 of the lkaros gene (Geor- 
gopoulos et al., 1994). 
lkaros cDNA Analysis 
RT-PCR analysis of total RNA prepared from thymus and spleen from 
wild-type and mutant mice was performed as previously described 
(Molnar and Georgopoulos, 1994) with the following modifications. 
Samples were denatured (94% for 15 s), annealed (60% for 20 s), 
and extended (72°C for 30 s) for 35 cycles. The relative concentration 
of cDNAs prepared from each tissue was determined using a set of 
primers that would amplify GAPDH cDNA for a number of cycles within 
the linear range of product amplification (data not shown). Adjusted 
amountsofcDNAswereamplifiedfor35cycleswithfoursetsof primers 
derivedfromexonsinsideandoutsidethedeleted region.Thesesetsof 
primers (Ex2F-Ex7Ff, Ex2F-ExGR, Ex3F-Ex7R, and Ex4F-Ex7R) allow 
the determination of exon usage by the lkaros transcripts. Sequences 
of the synthetic oligonucleotides (5’ to 3’) used as primers are as fol- 
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lows: Ex2F, CAC TAC CTC TGG AGC ACA GCA GAA; Ex3F, AGT 
AAT GTT AAA GTA GAG ACT CAG; Ex4F, GGT GAA CGG CCT TTC 
CAG TGC; ExGR, TCT GAG GCA TAG AGC TCT TAC; Ex7R, CAT 
AGG GCA TGT CTG ACA GGC ACT. 
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